Displaying 181-200 of 373 results for

Restrictions on flavored tobacco and nicotine products, including menthol, may reduce sales and reduce the number of new users.

Research confirms that strengthening economic supports can improve parental mental health, children’s health, education, and social outcomes.

The COVID-19 pandemic has had a particularly negative impact on the mental health of adolescent girls. Fortunately, state legislators have been addressing school-based mental health through legislation enacted since the beginning of the ...

Debra Houry, CDC's director of the National Center for Injury Prevention and Control discusses the impact of adverse childhood experiences and how discusses the prevention work that she and her team have done.

An ASTHO report describing the mental health impacts of COVID-19 on the workforce.

On Feb. 21, 2022, global health advocate Paul Farmer, MD, PhD, passed away. Farmer leaves behind a legacy of radical compassion, generosity, and a commitment to social justice. He will be remembered for his work making affordable, ...

How states are building sustainable health equity programs.

The COVID-19 pandemic introduced new challenges for screening children’s blood lead levels, as screening rates across the country dropped during stay-at-home orders. A substantive federal policy change and provisions in the Infrastructure ...

Lesley Steinman and Mark Snowden of the University of Washington Health Promotion Research Center discuss the PEARLS program and how it is being used to confront the stigma associated with depression and mental health.

One way states and territories can address ACEs in American Indian and Alaska Native communities is by adopting evidence-based home visiting programs that reflect the specific cultural values of the communities they are serving to reach ...

Heart disease is the leading cause of death in the United States, with approximately 30% of all heart disease deaths attributed to smoking cigarettes.

On April 12, 2023, ASTHO released a statement applauding the Office of National Drug Control Policy’s announcement designating fentanyl adulterated or associated with xylazine as an emerging drug threat to the United States.

On this episode of Public Health Review, we speak with representatives from public health, public safety, and community harm reduction programs to discuss their perspectives, experiences, and the importance of maintaining strong ...

ASTHO Statement on Rise in National Sexually Transmitted Disease Rates ARLINGTON, VA—Michael Fraser, CEO of the Association of State and Territorial Health Officials (ASTHO), issued the following statement in response to new preliminary ...

ASTHO Statement on FDA’s Announcement to Reduce Nicotine in Cigarettes ARLINGTON, VA—ASTHO’s chief medical officer, Marcus Plescia, issued the following statement on FDA’s announcement to reduce nicotine in cigarettes:  “We are ...

ASTHO Member and Delaware Health Official Karyl Rattay Testifies on Nation’s Opioid Epidemic ARLINGTON, VA—Karyl Rattay, MD, MS, director and state health officer at the Delaware Division of Public Health, testified today on the ...

Opioid and substance use disorders (SUD) continue to affect families beyond pregnancy; in 2017, about one in eight U.S. children lived in a household where at least one parent had a SUD in the prior year.

Increasing tobacco taxes in states is an effective method for encouraging cessation among youth. This brief outlines leading tobacco taxation strategies implemented by New York state, Washington, D.C., and Connecticut.

In February 2019, ASTHO surveyed its members to understand how data is being utilized to address these harms in their jurisdictions. This brief summarizes the results of this survey and highlights data-based approaches used to address four ...

This brief describes how the New Mexico Department of Health has enhanced its harm reduction program to provide an evidence-based comprehensive care model to support the health of people who use drugs. New Mexico’s success in leveraging ...